Caitlin John’s ResMed RMD Stock Holding History

Caitlin John’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.37K	Sell	15 -16	-52%	-$3.99K	﹤0.01%	664
2025 Q4	$7.47K	Sell	31 -5,664	-99%	-$1.45M	﹤0.01%	581
2025 Q3	$1.56M	Buy	5,695 +79	+1%	+$21.6K	1.08%	24
2025 Q2	$1.45M	Buy	5,616 +2,155	+62%	+$514K	1.32%	22
2025 Q1	$775K	Sell	3,461 -5,366	-61%	-$1.25M	0.76%	32
2024 Q4	$2.02M	Buy	8,827 +252	+3%	+$60.7K	1.33%	18
2024 Q3	$2.02M	Buy	+8,575	New	+$1.92M	1.26%	20

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Caitlin John's RMD Position: Q1 2026 in Review

Caitlin John reduced its ResMed (RMD) stake by 52% in Q1 2026, selling an estimated $3.99K and leaving 15 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Caitlin John first reported a position in RMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.02M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Caitlin John held 15 shares of ResMed worth $3.37K as of Q1 2026.
Caitlin John sold 16 ResMed shares in Q1 2026, an estimated $3.99K.
ResMed made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #664 holding.
Caitlin John first reported a position in ResMed in Q3 2024 and has held it in 7 quarters since.
Caitlin John's ResMed position peaked at $2.02M in Q3 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.